MDS Virtual Congress 2021

September 17-22, 2021. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Baseline and six months change in cortical perfusion in a mesenchymal stem cell trial for Parkinson’s disease

M. Schiess, J. Suescun, S. Chandra, V. Thyne, T. Ellmore (Houston, USA)
Baseline cognitive profile is closely associated with long-term motor prognosis in newly diagnosed Parkinson’s disease

SJ. Chung, YJ. Kim, YH. Sohn, PH. Lee (Yongin-Si, Republic of Korea)
BASELINE OLFACTION TESTING IN PARKINSON’S DISEASE PATIENTS IS CORRELATED WITH LONG-TERM DOPAMINERGIC DENERVATION IN STRIATAL SUB-REGIONS: LONGITUDINAL DATA FROM THE PPMI STUDY.

C. Koros, A-M. Simitsi, N. Papagiannakis, A. Prentakis, A. Bougea, D. Papadimitriou, R. Antonelou, I. Pachi, E. Angelopoulou, E. Stanitsa, I. Beratis, S. Papageorgiou, M. Stamelou, X. Trapali, L. Stefanis (Athens, Greece)
Be aware of pitfalls: Bioinformatic analysis of Cas9-targeted Nanopore sequencing of the RFC1 repeat in CANVAS

I. Wohlers, H. Pott, S. Schaake, J. Trinh, H. Busch, K. Lohmann (Lübeck, Germany)
Behavioral effects of stimulated dopamine release and D2-like receptor displacement in Parkinson’s patients with impulse control disorder

S. Lee, M. Aumann, A. Song, K. Hay, P. Diaz, Y. Yan, H. Kang, D. Claassen (Nashville, USA)
Belly Dancer’s Dyskinesia with Systemic Lupus Erythematosus: A Case Report

EAJ. Hutabarat, NA. Santosa (Surakarta, Indonesia)
Benefits of Treatment with OnabotulinumtoxinA in Naive and Non-naive Patients with Cervical Dystonia are Sustained over Time: Preliminary Completer Analysis from CD PROBE

P. Agarwal, M. Schwartz, A. Zuzek, A. Patel (Kirkland, USA)
Benign Progressive Supranuclear Palsy: mild pathology associated with parkinsonism

B. Couto, I. Martinez-Balbuena, S. Lee, N. Visanji, A. Lang, G. Kovacs (Toronto, Canada)
Beta synchronization of the subthalamic nucleus during self-initiated and externally generated movement in parkinsonian patients in OFF and ON states

V. Filyushkina, E. Belova, S. Usova, A. Tomskiy, A. Sedov (Moscow, Russian Federation)
Beta-antagonists and risk of Parkinson’s disease: Meta-analysis of real-world evidence studies

A. Singh, S. Hussain, B. Antony (Hobart, Australia)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z